US2023416350A1PendingUtilityA1
Tau-binding antibodies
Est. expiryJul 6, 2035(~9 yrs left)· nominal 20-yr term from priority
Inventors:David Edward Ormonde KnightTerence Seward BakerDavid James McmillanRobert GriffinGeorges Mairet-CoelloPatrick DowneyJean-Philippe Courade
A61K 2039/505G01N 33/6896A61P 25/28C07K 2317/24C07K 2317/92C07K 2317/94C07K 16/18C07K 14/4711C07K 2317/34C07K 2317/55C07K 2317/565C07K 2317/524C07K 2317/526C07K 2317/56C07K 2317/70C07K 2317/76
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to Tau-binding antibodies and binding fragments thereof.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An isolated Tau-binding antibody or binding fragment thereof, wherein said Tau-binding antibody or binding fragment thereof comprises:
a light chain variable region comprising a CDR1 selected from SEQ ID NO: 1, a CDR2 selected from SEQ ID NO: 2, and a CDR3 selected from SEQ ID NO: 3; and a heavy chain variable region comprising a CDR1 selected from SEQ ID NO: 4, a CDR2 selected from SEQ ID NO: 5, and/or a CDR3 selected from SEQ ID NO: 6.Join the waitlist — get patent alerts
Track US2023416350A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.